13 results match your criteria: "Buffalo General Hospital-Kaleida Health System[Affiliation]"

Bioterror, agroterror, and new diseases.

Discov Med

June 2007

Department of Medicine, School of Medicine and Biomedical Sciences - State University of New York at Buffalo, Buffalo General Hospital-Kaleida Health System, Buffalo, NY, 14203, USA.

As research techniques and biotechnology advance, the risk for potential bioterrorism increases due to the ease of creating or modifying virulent pathogenic microorganisms. In addition, the destruction of natural habitats to a range of animals and microbial species that are normally sequestered in these areas may bring forth new diseases to humans.

View Article and Find Full Text PDF

Breast cancer in intraductal carcinogen-treated non-human primates.

J Med

January 2008

Department of Pediatrics, State University of NY at Buffalo School of Medicine and Biomedical Sciences and the Graduate School, Buffalo General Hospital Kaleida Health System, Buffalo, NY 14203, USA.

Eight female Macaca arctoides monkeys were given dimethylbenzanthracene (DMBA) directly into the milk ducts. During a 4-year observation period, ending with euthanasia and autopsy, no mammary cancers were noticed. However, one animal developed a superficial localized squamous cell carcinoma.

View Article and Find Full Text PDF

Multiple medical problems following agent orange exposure.

J Med

January 2008

Department of Internal Medicine, Buffalo General Hospital/Kaleida Health System, State University of New York at Buffalo, School of Medicine and Biomedical Sciences, 14203, USA.

A patient exposed to agent orange and a gunshot wound during the Vietnam War has developed multiple medical problems including nocardiosis, onychomycosis (Trichophyton rubrum), multiple thromboembolic episodes, hemochromatosis, diabetes mellitus type 2, diabetic neuropathy, activated protein C resistance (without Leyden V 1st mutation), degree A-V block, lung cancer (metastatic adenocarcinoma), carpal tunnel syndrome and arthritis.

View Article and Find Full Text PDF

New approaches to the treatment of AIDS with special reference to overcoming interferon resistance.

J Med

January 2008

Department of Internal Medicine, Buffalo General Hospital/Kaleida Health System, State University of New York at Buffalo, School of Medicine & Biomedical Sciences and Graduate School, Buffalo, NY 14203, USA.

This is a brief review on studies of attacking HIV through a new angle. In previous studies, we have found that many patients with AIDS are resistant to interferon (IFN) therapy, and some develop resistance during therapy. Four factors were found to be responsible for the resistance of untreated patients: (a).

View Article and Find Full Text PDF

One-hundred forty male mice of an inbred strain (C3H/St) were divided into four groups of thirty-five each and were given total body irradiation of 750 cGy. After X-irradiation, one group was given etiocholanolone alone, the other was given bone marrow alone, a third was given both of these. One group was used as a control and was given no treatment after irradiation.

View Article and Find Full Text PDF

Treatment of viral and neoplastic diseases with double-stranded RNA derivatives and other new agents.

Exp Biol Med (Maywood)

September 2006

Department of Internal Medicine, State University of New York at Buffalo, Buffalo General Hospital/Kaleida Health System, 100 High Street, Buffalo, NY 14203, USA.

Many attempts have been made to inhibit viral and neoplastic diseases by targeting the RNA system. The pathophysiologic significance of the microRNA system and the therapeutic potential of its manipulation are discussed. Studies of double-stranded RNA derivatives are reviewed.

View Article and Find Full Text PDF

Attempts to induce differentiation of neoplastic cells to normal.

Discov Med

August 2005

Department of Internal Medicine, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo General Hospital-Kaleida Health System, Buffalo, NY 14203, USA.

Extract: It was a long time dream of oncologists to find agents which would cause differentiation to normal of neoplastic cells, thus "taming cancer" without harming normal cells. Our group was involved in such attempts for several decades. Here we summarize some of these studies as well as those of other investigators.

View Article and Find Full Text PDF

Resistance to interferons.

Discov Med

October 2004

Department of Medicine, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo General Hospital-Kaleida Health System, Buffalo, NY 14203, USA.

Extract: Interferons alpha, beta and gamma are a group of structurally and functionally related proteins, produced in response to viruses or double-stranded RNA and defined by their ability to establish an antiviral state in cells. They were originally discovered by Isaacs and Lindenmann (1957). Since their original discovery, several interferon genes and proteins have been identified.

View Article and Find Full Text PDF

Nutrition and infectious diseases in developing countries and problems of acquired immunodeficiency syndrome.

Exp Biol Med (Maywood)

June 2004

State University of New York at Buffalo, School of Medicine and Biomedical Sciences, and Department of Internal Medicine, Buffalo General Hospital/Kaleida Health System, New York 14203, USA.

Infectious diseases are the major causes of death and morbidity in underdeveloped countries, particularly in children. Increasing evidence suggests that malnutrition-both Protein-Energy type Malnutrition (PEM) and essential micronutrient (vitamins, trace minerals, essential amino acids, polyunsaturated fatty acids) type-is the underlying reason for increased susceptibility to infections. On the other hand, certain infectious diseases also cause malnutrition, which results in a vicious cycle.

View Article and Find Full Text PDF

Background: Many viral and neoplastic diseases are resistant to interferon-alpha/beta (IFN-alpha/beta) therapy or develop resistance during the course of IFN treatment. In patients with viral diseases, the authors identified four IFN inhibitors, of which the most important, most likely is a free IFN receptor of type 1 appearing in the circulation that captures and neutralizes IFN-alpha/beta.

Methods: Ninety-one cancer patients and 25 healthy individuals were studied.

View Article and Find Full Text PDF

Thromboembolic disorders are frequent complications in polycythemia vera. In addition to thrombocytosis with hyperaggregability, leukocytosis, and high hematocrit, hyperviscosity syndrome, a new component, is described in the pathophysiology of this phenomenon. There is decreased red cell membrane fluidity with decreased deformability which increases the susceptibility to microvascular occlusion and also increases the chance of disseminated intravascular coagulation (DIC).

View Article and Find Full Text PDF